Home / Research / by Lauren Feger

Real-world treatment outcomes of transcranial pulsating electromagnetic fields as augmentation therapy for treatment-resistant depression

Background: Treatment outcomes of patients who had received T-PEMF as an augmenting therapy at Aalborg University Hospital, Aalborg, Denmark, was evaluated.

Highlights
•An episode duration <2 years is associated with higher odds for achieving response.
•Eight weeks of augmenting therapy with T-PEMF reduced depressive symptoms.
•Eight weeks of augmenting therapy with T-PEMF increased the quality of life.
•Treatment outcomes of T-PEMF were investigated in a real-world clinical setting.

Methods: Patients diagnosed with unipolar depression or bipolar disorder who had received a self-administered 8-week T-PEMF series between November 2019 and April 2023 were included. Data were retrieved from the patients’ records. The primary outcome was the Hamilton Rating Scale for Depression 17-item version (HAMD17), both as a continuous measure and with proportions of response and remission reported.

Results: A total of 57 patients (65.1 % females, 86.0 % unipolar depression, mean age, 48 ± 14 years) were included. Duration of current depressive episode was almost equally divided for <2 years (38.6 %), 2-5 years (38.6 %) and > 5 years (22.8 %). HAM-D17 decreased significantly from baseline (20.8 (SD: 3.3)) to week 8 (14.5 (SD: 6.2), p < 0.001). An episode duration of 2-5 years was associated with lower odds of response on HAM-D6 (adjusted OR = 0.15, 95 % CI: 0.03; 0.96, p < 0.05) and self-rated HAM-D6 (adjusted OR = 0.09, 95 % CI: 0.01; 0.99, p = 0.05) when compared to an episode duration <2 years.

Limitations: This study is limited by a lack of a control group, limited controlling of confounders, small sample sizes, and an attrition rate of 29.8 % for the primary outcome.

Conclusion: T-PEMF reduced depressive symptoms in a real-world clinical setting including patients with both unipolar depression and bipolar disorder. Receiving T-PEMF within the first 2 years of the depressive episode was associated with an improved outcome.

Keywords: Real-world data; Transcranial pulsating electromagnetic fields; Treatment-resistant depression.

LINK

Share this story, choose your platform!

Have a Question?

We’re here to help! Whether you’re curious about membership, certification, or using PEMF in your practice, our team is happy to answer your questions and point you in the right direction.
Complete the form below and we will be in touch soon.
Contact Us

Become a Member

Research

Gain access to all our research articles

Discounts

Use our Member Discounts Program

Certifications

Get AOPP Certified
You are enjoying 1 of 2 free previews